Diabetes Complications  >>  Cubicin (daptomycin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT01199783 / 2010-022348-18: Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment

Terminated
3
1
Europe
Daptomycin, Cubicin, Vancomycin
Ruhr University of Bochum
Diabetic Foot
10/13
12/13

Download Options